Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-114778
Filing Date
2024-11-06
Accepted
2024-11-06 16:01:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2427567d2_defa14a.htm DEFA14A 13583
2 GRAPHIC tm2427567d1ex99-1img001.jpg GRAPHIC 14646
3 GRAPHIC tm2427567d1ex99-1img002.jpg GRAPHIC 4358
  Complete submission text file 0001104659-24-114778.txt   41111
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40363 | Film No.: 241430792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)